BSE: 532540 NSE: Suven Pharmaceuticals ISIN: INE467B01029 SECTOR: IT Software Company Company’s Website: IPO Date & Price: July 29, 2004 | Rs.
Suven Pharmaceuticals Overview:
| Stock Symbol in NSE | Stock Symbol in BSE | Current Price | Market Cap. (Cr) | P/E Ratio | Current EPS |
|---|
Suven Pharmaceuticals Sector Performance and Peer Comparison with Sector Analysis:
Did You Know?
<Space for Feature Image>
- Suven Pharmaceuticals is the
- Its Belong to Group.
Balance Sheets & Profit & Loss Account:
| Year | Mar 2019 | Mar 2020 |
|---|
Suven Pharmaceuticals Share Price Forecast Based on Current Growth +5/-5:
Share Price and EPS Forecast Based on Current Average Growth Rates:
| Next 5 Years (CG) | Next 20 Years (CG) | Next 10 Years (CG) |
|---|
Share Price and EPS Forecast Based on Current Average Growth Rates Plus 5%:
| Next 5 Years (CG+5%) | Next 10 Years (CG+5%) | Next 20 Years (CG+5%) |
|---|
Share Price and EPS Forecast Based on Current Average Growth Rates Minus 5%:
| Next 20 Years (CG-5%) | Next 10 Years (CG-5%) | Next 5 Years (CG-5%) |
|---|
Suven Pharmaceuticals Quarterly Result, Date & Street Estimate:
| Share Name | Quarter Results | Year | Street Estimates | Profits | Growth |
|---|
Fundamental Analysis of Suven Pharmaceuticals :
Suven Pharmaceuticals Share Long Term Investment Price Target:
| Price | Long Term Investment Tagets | Qnt.Ratio |
|---|
Suven Pharmaceuticals Fundamentals SWAT Analysis by AMT
Strengths, Weaknesses, Opportunities, and Threats of Suven Pharmaceuticals
S
- Strengths Analysis will coming Soon.
W
- Weakness Analysis will coming Soon.
O
- Opportunity Analysis will coming Soon.
T
- Threats Analysis will coming Soon.
Where we can See Suven Pharmaceuticals in Next 5 Year, 10 Year & 20 Year?
Technical Analysis of Suven Pharmaceuticals :
Suven Pharmaceuticals Share Weekly Swing Trading Price Target:
| Demand And Supply Zone | Support Levels | Support Price | Resistance Levels | Resistance Price |
|---|
Suven Pharmaceuticals Share Today Intraday Price Target:
| IntradayTarget Today [Short Selling] | IntradayTarget Today [Long Buying] |
|---|
FAQ on Suven Pharmaceuticals :
Yes, Suven Pharmaceuticals is India Number-1 IT Software company, with lots business potential in next few year. Its Fundamentally strong Stock we recommend to buy at around 20-25 PE Ration price target. Anyway This company is quite famous for Good Dividends.
Suven Pharmaceuticals is a Debt free company. Its can easily survived any down turn for 5-10 Quarter business growth.
Currently Suven Pharmaceuticals is Trading at P/E Ratio which is
Both and working as a
Do to Covid-19 pandemic Suven Pharmaceuticals Share drastically fall.
Its depend on when you and at what price you have buy this share, Suven Pharmaceuticals at 20-25 P/E Ration is a excellent buy call for long Term Investment.
Suven Pharmaceuticals ‘s Products/Projects:
| Products/Projects | Description/Valuation |
| A. | |
| B. | |
| C. |
IPO, Split, Bonus, Dividend Buyback History:
Suven Pharmaceuticals First IPO was initiate on July 29, 2004. equity shares were put on sale during the IPO with a price band of Rs -Rs per equity share.
[ninja_tables id=”82019″
Company Profile:
| CEO Name | Venkateswarlu Jasti |
| CFO Name | M Mohan Kumar |
| CEO Salary | N/A |
| Company Address | 3rd Floor, # 8-2-334, SDE Serene Chambers, Rd Number 5, Avenue – 7, Banjara Hills, Hyderabad, Telangana 500034 |
| Contact Number | 040 2354 9414 |
| Email Address | contactsuvenusa@suven.com … |
Declaration: Investing in the Stock market is full of Risky. AllMoneyTips.COM doesn’t give any guarantee or warranted on its investment advice. Do your research before investing in the stock market. Our Forecast and buying selling levels of stocks is based on price action and demand and supply zone. There is no guarantee come with our prediction. Take it as advice only. We are not responsible for your losses on your investments.